20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 12, 2009, Pages 3320-3323

  Liu, Jie ^a   Shiono, Jun ^a   Shimizu, Kuniyoshi ^a   Yu, Hongshan ^b   Zhang, Chunzhi ^b   Jin, Fengxie ^b   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b DALIAN POLYTECHNIC UNIVERSITY   (China)

Author keywords

Bone protection; Ginsenosides 20(R) Rh2; Osteoclast

Indexed keywords

20 GINSENOSIDE RH2; GINSENOSIDE RH 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; NONHUMAN; OSTEOBLAST; OSTEOCLAST; RAT; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; GINSENOSIDES; HUMANS; MICE; OSTEOCLASTS; STEREOISOMERISM;

PANAX GINSENG;

EID: 65749114119     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.04.054     Document Type: Article

References (29)

1. Hofbauer L.C., and Schoppet M. JAMA 292 (2004) 490
2. Roodman G.D. N. Eng. J. Med. 64 (2004) 9209
3. Shin H.Y., Jeong H.J., An H.J., Hong S.H., Um J.Y., Shin T.Y., Kwon S.J., Jee S.Y., Seo B.I., Shin S.S., Yang D.C., and Kim H.M. Indian J. Med. Res. 124 (2006) 199
4. Wang W., Zhao Y., Rayburn E.R., Hill D.L., Wang H., and Zhang R. Cancer Chemother. Pharmacol. 59 (2007) 589
5. Polan M.L., Hochberg R.B., Trant A.S., and Wuh H.C. J. Womens Health (Larchmt.) 13 (2004) 427
6. Kim H.R., Cui Y., Hong S.J., Shin S.J., Kim D.S., Kim N.M., So S.H., Lee S.K., Kim E.C., Chae S.W., and Chae H.J. Immunopharmacol. Immunotoxicol. 30 (2008) 333
7. Baek N.I., Kim D.S., Lee Y.H., Park J.D., Lee C.B., and Kim S.I. Planta Med. 62 (1996) 86
8. Kang D.I., Lee J.Y., Yang J.Y., Jeong S.M., Lee J.H., Nah S.Y., and Kim Y. Biochem. Biophys. Res. Commun. 333 (2005) 1194
9. Lee E., Kim S., Chung K.C., Choo M.K., Kim D.H., Nam G., and Rhim H. Eur. J. Pharmacol. 536 (2006) 69
10. Bae E.A., Han M.J., and Kim E.J. Arch. Pharm. Res. 27 (2004) 61
11. Shibata S. J. Korean Med. Sci. 16 (2001) S28
12. Liu W.K., Xu S.X., and Che C.T. Life Sci. 67 (2000) 1297
13. Popovich D.G., and Kitts D.D. J. Biochem. Mol. Toxicol. 18 (2004) 143
14. Kim H.S., Lee E.H., Ko S.R., Choi K.J., Park J.H., and Im D.S. Arch. Pharm. Res. 27 (2004) 429
15. Lee J.Y., Shin J.W., Chun K.S., Park K.K., Chung W.Y., Bang Y.J., Sung J.H., and Surh Y.J. Carcinogenesis 26 (2005) 359
16. Korsmeyer S.J. Cancer Res. 59 (1999) 1693s
17. Fukamachi Y., Karasaki Y., Sugiura T., Itoh H., Abe T., Yamamura K., and Higashi K. Biochem. Biophys. Res. Commun. 246 (1998) 364
18. Yang Z.G., Sun H.X., and Ye Y.P. Chem. Biodivers. 3 (2006) 187
19. Liu H.Y., and Zhang C.Q. Asian-Aust. J. Anim. Sci. 19 (2006) 958e63
20. Min J.K., Kim J.H., Cho Y.L., Maeng Y.S., Lee S.J., and Pyun B.J. Biochem. Biophys. Res. Commun. 349 (2006) 987e94
21. Miyamoto I., Liu J., Shimizu K., Sato M., Kukita A., Kukita T., and Kondo R. Eur. J. Pharmacol. 602 (2009) 1
22. Bae E.A., Han M.J., Choo M.K., Park S.Y., and Kim D.H. Biol. Pharm. Bull. 25 (2002) 58
23. Park J.A., Kim K.W., Kim S.I., and Lee S.K. Eur. J. Biochem. 257 (1998) 242
24. Jin Y.H., Yim H., Park J.H., and Lee S.K. Biochem. Biophys. Res. Commun. 305 (2003) 974
25. Popov A.M. Izv. Akad. Nauk. Ser. Biol. (2002) 155
26. Martinez-Botas J., Suarez Y., Ferruelo A.J., Gomez- Coronado D., and Lasuncion M.A. FASEB J. 13 (1999) 1359
27. Mizagomi M., Tsuchiya H., Ueno T., Kashimata M., and Takakura K. Reg. Anesth. Pain Med. 33 (2008) 304
28. Jin F., Yu H., and Bao Y. Zhuanli Shenqing Gongkai Shuomingshu (1999) 5
29. Watanabe T., Kukita T., Kukita A., Wada N., Toh K., Nagata K., Nomiyama H., and Iijima T.J. Endocrinology 180 (2004) 193